Clinical laboratory tests associated with survival in patients with metastatic renal cell carcinoma: A Laboratory Wide Association Study (LWAS)-Reference-Cited by-同舟云学术

Clinical laboratory tests associated with survival in patients with metastatic renal cell carcinoma: A Laboratory Wide Association Study (LWAS)

Published:2022-01 Issue:1 Volume:40 Page:12.e23-12.e30
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Velaer Kyla,Thomas I-Chun^ORCID,Yang Jaden,Kapphahn Kristopher,Metzner Thomas J.,Golla Abhinav,Hoerner Christian R.^ORCID,Fan Alice C.,Master Viraj,Chertow Glenn M.,Brooks James D.^ORCID,Patel Chirag J.,Desai Manisha,Leppert John T.^ORCID

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference31 articles.

1. Cancer statistics, 2020;Siegel;CA Cancer J Clin,2020

2. Utilization of cytoreductive nephrectomy and patient survival in the targeted therapy era;Conti;Int J Cancer,2014

3. Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials;Gan;Eur J Cancer,2021

4. The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study;Ko;Lancet Oncol,2015

5. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma;Motzer;J Clin Oncol,1999

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations;Clinical & Experimental Metastasis;2024-02-16

2. External Validation of a Red Cell-based Blood Prognostic Score in Patients With Metastatic Renal Cell Carcinoma Treated With First- Line Immunotherapy Combinations;2023-10-10

3. Groundwater constituents and the incidence of kidney cancer;Cancer;2023-06-07